Clinical trial
SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
NCT01810341 is registered in ClinicalTrials.gov with SynapDx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SynapDx Autism Spectrum Disorder Gene Expression Analysis Study
- Lead sponsor
- SynapDx
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- December 31, 2014
- Enrollment
- 880 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
autism